Bridgette J. Connell

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Driving innovation from discovery to access: Meeting report of the 7 th Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil).

Driving innovation from discovery to access: Meeting report of the 7 th Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil).

Journal: Gates open research

Published: August 23, 2025

Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.

Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.

Journal: Scientific reports

Published: March 20, 2020

An inkjet-printed polysaccharide matrix for on-chip sample preparation in point-of-care cell counting chambers.

An inkjet-printed polysaccharide matrix for on-chip sample preparation in point-of-care cell counting chambers.

Journal: RSC advances

Published: February 20, 2020

CCR5 structural plasticity shapes HIV-1 phenotypic properties.

CCR5 structural plasticity shapes HIV-1 phenotypic properties.

Journal: PLoS pathogens

Published: September 06, 2018

All-printed cell counting chambers with on-chip sample preparation for point-of-care CD4 counting.

All-printed cell counting chambers with on-chip sample preparation for point-of-care CD4 counting.

Journal: Biosensors & bioelectronics

Published: March 16, 2018

Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4.

Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4.

Journal: Science signaling

Published: November 03, 2016

A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation.

A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation.

Journal: PloS one

Published: January 25, 2016

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 08, 2015

Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients.

Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients.

Journal: International journal of antimicrobial agents

Published: May 18, 2015

Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition.

Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition.

Journal: Frontiers in immunology

Published: September 23, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026